Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2007
10/10/2007EP1841782A2 Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
10/10/2007EP1841467A2 Combination cancer therapy with anti-psma antibodies
10/10/2007EP1841456A2 Stabilized liquid polypeptide formulations
10/10/2007EP1841455A1 Humanized anti-amyloid antibody
10/10/2007EP1841454A2 Treatment method
10/10/2007EP1841452A2 Single domain antibodies against tnfr1 and methods of use therefor
10/10/2007EP1601450A4 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
10/10/2007EP1511859B1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
10/10/2007EP1385882B1 Peptides and related molecules that bind to tall-1
10/10/2007EP1380653B1 Method of assaying lupus anticoagulant and assay reagent
10/10/2007EP1177301B1 Chlamydia antigens and corresponding dna fragments and uses thereof
10/10/2007EP1173195B1 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/10/2007EP1090924B1 Tumor antigen peptides originating in cyclophilin b
10/10/2007EP1068241B1 Antibody variants and fragments thereof
10/10/2007EP0870014B9 Aldolase catalytic antibody
10/10/2007EP0666760B2 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
10/10/2007CN101052877A Cytoxan antibodies and immunoassay
10/10/2007CN101052728A Method of efficiently screening protein capable of specific binding to ligand
10/10/2007CN101052726A IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/10/2007CN101052655A CTLA-4 antibody and aromatase inhibitor combination of treatment for breast cancer
10/10/2007CN101052654A Polypeptide variants with altered effector function
10/10/2007CN101052653A Anti-Fc-gamma RIIB receptor antibody and uses therefor
10/10/2007CN101052652A 结合分子 Binding molecules
10/10/2007CN101052415A Methods and compositions for treating and preventing inflammatory conditions
10/10/2007CN101052412A Amebiasis subunit vaccine
10/10/2007CN101050464A Method for preparing A gene of recombined protein, and expressed products and application
10/10/2007CN101050459A Mature Doppel of Chinese yellow cattle, and method for preparing polyclonal antibody
10/10/2007CN100341896C Anti-GP39 antibodies and uses therefor
10/10/2007CN100341892C Labelled molecule capable of identifying reactive astrocytes and use thereof
10/10/2007CN100341891C Tanscription activating factor genes of candida albicans and their use
10/10/2007CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/10/2007CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
10/10/2007CA2564435A1 Methods for monitoring and treating intestinal disorders
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279562 Rapamycin conjugates
10/09/2007US7279561 Anti-rapamycin monoclonal antibodies
10/09/2007US7279560 Administering monoclonal antibodies to inhibit transmission of costimulatory signal of lymphocytes; antiallergens; autoimmune diseases
10/09/2007US7279559 Antibody which immunologically reacts with an interleukin 22 protein
10/09/2007US7279556 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response
10/09/2007US7279552 Pro1782 polypeptides
10/09/2007US7279457 Stability and rapid onset of action; may be administered via buccal administration, sublingual administration, pulmonary delivery, nasal administration, subcutaneous administration, rectal administration, vaginal administration, or ocular administration
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279307 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007US7279292 Methods for diagnosis of low grade astrocytoma
10/09/2007US7279291 Polypeptides having a triggering NK activity and biological applications
10/09/2007US7279290 ATM kinase compositions and methods
10/09/2007US7279274 Method for diagnosing diabetes in a mammal
10/09/2007US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis
10/09/2007US7279167 Nucleotide sequences coding viral protein for use in treatment and prevention of viral disease in fish; veterinary medicine
10/09/2007US7279161 Treating patients afflicted with hemophilia A by administering an antibody that binds factor IX/factor IXa and increases the procoagulant activity of FIXa
10/09/2007US7279160 Combinations of DR5 antibodies and other therapeutic agents
10/09/2007US7279158 Methods for the treatment of inflammatory joint disease
10/09/2007US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
10/09/2007CA2327261C Nicotianamine synthase and gene encoding the same
10/09/2007CA2257115C Spruce budworm antifreeze proteins, genes and methods of using same
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/04/2007WO2007112362A2 Construction of a multivalent scfv through alkyne-azide 1,3-dipolar cycloaddition
10/04/2007WO2007112193A2 Camptothecin-binding moiety conjugates
10/04/2007WO2007112146A2 Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases
10/04/2007WO2007111965A2 Hepatitis c virus neutralizing antibodies
10/04/2007WO2007111661A2 Human antibodies specific for gastrin materials and methods
10/04/2007WO2007110678A2 Neutralizing antibodies and methods of use thereof
10/04/2007WO2007110648A1 Agonist antibodies against tshr
10/04/2007WO2007110631A1 Binding member for gm-csf receptor
10/04/2007WO2007110339A1 Anti-igf-1r human monoclonal antibody formulation
10/04/2007WO2007110219A1 Medical delivery device for therapeutic proteins based on single domain antibodies
10/04/2007WO2007110209A1 Biological materials and uses thereof
10/04/2007WO2007093657A3 Method for the molecular diagnosis of prostate cancer and kit for implementing same
10/04/2007WO2007084672A3 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
10/04/2007WO2007084107A3 Monoclonal antibodies that neutralize anthrax protective antigen (pa) toxin
10/04/2007WO2007071422A3 Pharmaceutical antibody compositions with resistance to soluble cea
10/04/2007WO2007068485A3 Biological materials and uses thereof
10/04/2007WO2007064742B1 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
10/04/2007WO2007049152A3 Methods of producing stable b-lymphocytes
10/04/2007WO2007042289A3 Nanobodies™ and polypeptides against egfr and igf-ir
10/04/2007WO2007041573A3 Crystal structure of human urokinase plasminogen activator amino terminal fragment bound to its receptor
10/04/2007WO2007038641A3 Methods and therapies for treating inflammatory conditions with exposed collagen
10/04/2007WO2007038637A3 Human monoclonal antibodies to cd70
10/04/2007WO2007030012A3 Extracellular matrix imaging
10/04/2007WO2007028005A3 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
10/04/2007WO2006126069A3 A method for the production of a monoclonal antibody to cd20 for the treatment of b-cell lymphoma
10/04/2007WO2006122825A3 Single domain vhh antibodies against von willebrand factor
10/04/2007WO2006071949A3 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
10/04/2007WO2005079523A3 Novel teleost derived antimicrobal polypeptides
10/04/2007WO2002059258A3 Chimeric proteins for prevention and treatment of hiv infection
10/04/2007US20070232790 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
10/04/2007US20070232535 GFRalpha3 and its uses
10/04/2007US20070232520 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
10/04/2007US20070231893 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein
10/04/2007US20070231857 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/04/2007US20070231843 Monoclonal antibody for use in detection of spongiform encephalopathy and brain disorders
10/04/2007US20070231840 Spore specific antigen
10/04/2007US20070231839 N-(3-oxododecanoyl)-L-homoserine lactone, binding to carrier; used as vaccine or to raise and subsequently isolate antibodies or binding portions thereof which are capable of recognizing and binding to the autoinducer; carrier molecule comprises a lysine-containing protein, such as bovine serum albumin
10/04/2007US20070231831 The human E3alpha ubiquitin ligase family
10/04/2007US20070231820 P450 enzymes, nucleic acids encoding them and methods of making and using them
10/04/2007US20070231814 DNA sequences isolated from human colonic epithelial cells
10/04/2007US20070231408 Colloidal metal compositions and methods
10/04/2007US20070231378 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1494